The role of radiation therapy after incomplete resection of penile cancer

Strahlentherapie und Onkologie

Volumn 184, Issue 7, 2008, Pages 359-363

  Langsenlehner, Tanja ^a   Mayer, Ramona ^a   Quehenberger, Franz ^a   Prettenhofer, Ulrike ^a   Langsenlehner, Uwe ^a   Pummer, Karl ^a   Kapp, Karin S ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adjuvant treatment; Incomplete resection; Penile cancer; Radiotherapy

Indexed keywords

IRIDIUM 192;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MALE; MEGAVOLTAGE RADIOTHERAPY; OVERALL SURVIVAL; PENIS AMPUTATION; PENIS CANCER; RADIATION DOSE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PENILE NEOPLASMS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES;

EID: 56549105023     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1818-2     Document Type: Article

References (40)

1. Agrawal A, Pai D, Ananthakrishnan N, et al. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int 2000;85:299-301.
2. Bermejo C, Busby JE, Spiess PE, et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007;177:1335-8.
3. Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol 2002;167:1638-42.
4. Bezerra AL, Lopes A, Santiago GH, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001;91:2315-21.
5. Bissada NK, Yakout HH, Fahmy WE, et al. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol 2003;169:500-2.
6. Block T, Czempiel H, Zimmermann F. Transperineal permanent seed implantation of "low-risk" prostate cancer: 5-year-experiences in 118 patients. Strahlenther Onkol 2006;182:666-71.
7. Busby JE, Pettaway CA. What's new in the management of penile cancer? Curr Opin Urol 2005;15:350-7.
8. Chaudhary AJ, Ghosh S, Bhalavat RL, et al. Interstitial brachytherapy in carcinoma of the penis. Strahlenther Onkol 1999;175:17-20.
9. Chen MF, Chen WC, Wu CT, et al. Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan. World J Urol 2004;22:60-6.
10. Crook JM, Jezioranski J, Grimard L, et al. Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 2005;62:460-7.
11. Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol 2003;170:359-65.
12. Ficarra V, D'Amico A, Cavalleri S, et al. Surgical treatment of penile carcinoma: our experience from 1976 to 1997. Urol Int 1999;62:234-7.
13. Ficarra V, Zattoni F, Artibani W, et al. G.U.O.N.E. Penile Cancer Project Members. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol 2006;175:1700-4.
14. Goldner G, Wachter S, Wachter-Gerstner N, et al. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy). Strahlenther Onkol 2006;182:537-42.
15. Gotsadze D, Matveev B, Zak B, et al. Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol 2000;38:306-12.
16. Hakenberg OW, Wirth MP. Issues in the treatment of penile carcinoma. A short review. Urol Int 1999;62:229-33.
17. Heidenreich A, Jakse G. Neoadjuvant and adjuvant chemotherapy in patients with advanced penile cancer. Urologe A 2007;46:1395-9.
18. Hoffman MA, Renshaw AA, Loughlin KR. Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer 1999;85:1565-8.
19. Kattan MW, Ficarra V, Artibani W, et al. GUONE Penile Cancer Project Members. Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. J Urol 2006;175:2103-8.
20. Kiltie AE, Elwell C, Close HJ, et al. Iridium-192 implantation for node-negative carcinoma of the penis: the Crookridge Hospital experience. Clin Oncol (R Coll Radiol) 2000;12:25-31.
21. Kroon BK, Horenblas S, Lont AP, et al. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 2005;173:816-9.
22. Mahlmann B, Doehn C, Feyerabend T. Radiotherapy of penis carcinoma. Urologe 2001;40:308-12.
23. McDougal WS. Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol 1995;154:1364-6.
24. McLean M, Akl AM, Warde P, et al. The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 1993;25:623-8.
25. Mobilio G, Ficarra V. Genital treatment of penile carcinoma. Curr Opin Urol 2001;11:299-304.
26. Müller AC, Diestelhorst A, Kuhnt T, et al. Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer. Strahlenther Onkol 2007;183:177-83.
27. Nelson BA, Cookson MS, Smith JA Jr, et al. Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series. J Urol 2004;172:494-7.
28. Ozsahin M, Jichlinski P, Weber DC, et al. Treatment of penile carcinoma: to cut or not to cut? Int J Radiat Oncol Biol Phys 2006;66:674-9.
29. Petera J, Odrazka K, Zouhar M, et al. High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma. Strahlenther Onkol 2004;180:123-5.
30. Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int 2004;94:1253-7.
31. Sanchez-Ortiz RF, Pettaway CA. The role of lymphadenectomy in penile cancer. Urol Oncol 2004;22:236-44.
32. Sarin R, Norman AR, Steel GG, et al. Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int J Radiat Oncol Biol Phys 1997;38:713-22.
33. Slaton JW, Morgenstern N, Levy DA, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 2001;165:1138-42.
34. Solsona E, Algaba F, Horenblas S, et al. European Association of Urology. EAU Guidelines on Penile Cancer. Eur Urol 2004;46:1-8.
35. Solsona E, Iborra I, Rubio J, et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001;165:1506-9.
36. Soria JC, Fizazi K, Piron D, et al. Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 1997;8:1089-98.
37. Tseng HF, Morgenstern H, Mack T, et al. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 2001;12:267-77.
38. Weiss W, Horninger W, Forthuber BC, et al. Single-institution results of primary external-beam radiation for the treatment of T1-T3 prostate cancer. Strahlenther Onkol 2007;183:321-6.
39. Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol 2003;169:2118-21.
40. Zouhair A, Coucke PA, Jeanneret W, et al. Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis. Eur J Cancer 2001;37:198-203.